FDA Approves Anike / Penpulimab-kcqx for Non-Keratinizing Nasopharyngeal Carcinoma: Key Insights for Oncologists Head and Neck 4 Mins Read FDA approves Penpulimab-kcqx / Anike The FDA approved Anike (Penpulimab-kcqx) on April 23, 2025, for non-keratinizing nasopharyngeal carcinoma (NPC, WHO…
